Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Serum B-type natriuretic peptide does not increase with higher systolic blood pressure in obese men despite evidence of blood pressure-related increases in left ventricular mass and filling pressure

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Jan Fahrenkrug (6/6 1947 - 10/11 2021)

    Research output: Contribution to journalEditorialResearchpeer-review

  2. Arterial responses to infusion of glucagon-like peptide-1 in humans: A randomized trial study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. On premises and principles for measurement of gastrointestinal peptide hormones

    Research output: Contribution to journalReviewResearchpeer-review

  4. Processing-independent analysis (PIA): a method for quantitation of the total peptide-gene expression

    Research output: Contribution to journalReviewResearchpeer-review

  1. Diagnostic and prognostic value of the electrocardiogram in stable outpatients with type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Deep learning based low-activity PET reconstruction of [11C]PiB and [18F]FE-PE2I in neurodegenerative disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Genetic analyses of the electrocardiographic QT interval and its components identify additional loci and pathways

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

B-type natriuretic peptide (BNP) is a cardiac hormone secreted predominantly from the ventricles in response to increased ventricular pressure. Along this line, hypertensive patients with left ventricular hypertrophy typically have high circulating BNP concentrations. BNP has natriuretic and vasodilatory actions. Obese persons have low circulating BNP concentrations, and a relative lack of this natriuretic and vasodilatory factor could contribute to obesity-related hypertension. The relationship between BNP, BP, left ventricular mass (LVM), and left ventricular filling pressure among obese persons is not clear. To address this issue, we studied 98 healthy obese medication-free men with normal left ventricular ejection fraction. We measured BP using 24 -h ambulatory (A) BP recordings, LVM and E/e', an estimate of left ventricular filling pressure, using echocardiography, and fasting BNP in serum. Mean systolic ABP ± SD was 114 ± 4 mm Hg in 1st and 149 ± 8 mm Hg in 4th systolic ABP quartile, P < 0.001. LVM and E/e' increased across systolic ABP quartiles (mean LVM±SD: 81.5±13.7 g/m2 in 1st and 100.1 ± 26.7 g/m2 in 4th quartile, P = 0.018; mean E/e'±SD: 5.3±1.6 in 1st and 7.0 ± 2.0 in 4th quartile, P = 0.002). In contrast, serum BNP did not increase across systolic ABP quartiles (median (IQR): 6.7 (3.1-12.3) pg/ml in 1st and 5.3 (2.8-9.7) pg/ml in 4th quartile, P = 0.75). Unexpectedly, among healthy obese medication-free men, serum BNP does not increase with higher systolic ABP despite evidence of BP-related increases in LVM and E/e'. This further suggests that a relatively low amount of circulating BNP could contribute to obesity-related hypertension in its early stages.

Original languageEnglish
JournalPeptides
Volume134
Pages (from-to)170390
ISSN0196-9781
DOIs
Publication statusPublished - Dec 2020

Bibliographical note

Copyright © 2020 Elsevier Inc. All rights reserved.

    Research areas

  • B-type natriuretic peptide, Blood pressure, E/e', Left ventricular hypertrophy, Left ventricular mass, Obesity

ID: 60791876